628 / 1456
•
Multicenter study
•
Reirradiation (mean time 38 months)
•
Recurrent head and neck cancer
•
N=60, mediam age 69 y.
•
Period: 2007-2010
•
Grade 3 toxicity: 18%
•
RECIST complete response 49%
•
OS: 47,5%
•
F/u: 11,4 m.
•
SBRT
•
Dose: 36 Gy at 6 Gy/fx + cetuximab
Lartigau et al. Radiotherapy and Oncology 109 (2013) 281–285